UK markets open in 7 hours 5 minutes

ACADIA Pharmaceuticals Inc. (ACAD)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
15.76+0.42 (+2.74%)
At close: 04:00PM EST
15.76 0.00 (0.00%)
After hours: 04:56PM EST
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
511,503
484,145
441,755
339,076
223,807
Cost of revenue
10,314
19,141
20,550
19,598
18,330
Gross profit
501,189
465,004
421,205
319,478
205,477
Operating expenses
Research development
352,779
239,415
319,130
240,385
187,163
Selling general and administrative
370,600
396,028
388,661
325,638
265,758
Total operating expenses
723,379
635,443
707,791
566,023
452,921
Operating income or loss
-222,190
-170,439
-286,586
-246,545
-247,444
Total other income/expenses net
3,622
2,329
-997
997
-1,840
Income before tax
-215,459
-167,519
-280,973
-234,383
-243,936
Income tax expense
1,885
351
611
876
1,256
Income from continuing operations
-217,344
-167,870
-281,584
-235,259
-245,192
Net income
-217,344
-167,870
-281,584
-235,259
-245,192
Net income available to common shareholders
-217,344
-167,870
-281,584
-235,259
-245,192
Basic EPS
-
-1.05
-1.79
-1.60
-1.94
Diluted EPS
-
-1.05
-1.79
-1.60
-1.94
Basic average shares
-
160,493
157,331
147,199
126,583
Diluted average shares
-
160,493
157,331
147,199
126,583
EBITDA
-
-167,095
-283,654
-243,779
-244,439